↓ Skip to main content

American Association for Cancer Research

Inhibition of dUTPase Induces Synthetic Lethality with Thymidylate Synthase–Targeted Therapies in Non–Small Cell Lung Cancer

Overview of attention for article published in Molecular Cancer Therapeutics, March 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

patent
22 patents

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
58 Mendeley
Title
Inhibition of dUTPase Induces Synthetic Lethality with Thymidylate Synthase–Targeted Therapies in Non–Small Cell Lung Cancer
Published in
Molecular Cancer Therapeutics, March 2012
DOI 10.1158/1535-7163.mct-11-0781
Pubmed ID
Authors

Peter M. Wilson, Melissa J. LaBonte, Heinz-Josef Lenz, Philip C. Mack, Robert D. Ladner

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Japan 1 2%
Hungary 1 2%
Denmark 1 2%
Unknown 54 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 17%
Researcher 9 16%
Student > Bachelor 9 16%
Student > Master 6 10%
Student > Doctoral Student 4 7%
Other 12 21%
Unknown 8 14%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 15 26%
Agricultural and Biological Sciences 15 26%
Medicine and Dentistry 8 14%
Chemistry 5 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 3 5%
Unknown 10 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 February 2023.
All research outputs
#7,689,410
of 23,394,907 outputs
Outputs from Molecular Cancer Therapeutics
#1,704
of 3,911 outputs
Outputs of similar age
#52,315
of 157,471 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#35
of 60 outputs
Altmetric has tracked 23,394,907 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,911 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 157,471 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.